Mydecine gets first CGMP status to produce, sell and export medical psilocybin

Mugglehead
By Jared GnamAug 19, 2020, 9:15 pm239 pts
With depression on the rise during the pandemic, Mydecine Innovations Group Inc. (CSE: MYCO) says it’s blazing new trails for global psilocybin research to help the afflicted. On Tuesday, the Denver-based psychedelic company said it’s the first to gain Current Good Manufacturing Practice capabilities to…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Texas gov. makes final hour decision on hemp ban 70

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 64

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.